These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29233975)

  • 1. Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data.
    Schalling M; Gleiss A; Gisslinger B; Wölfler A; Buxhofer-Ausch V; Jeryczynski G; Krauth MT; Simonitsch-Klupp I; Beham-Schmid C; Thiele J; Gisslinger H
    Blood Cancer J; 2017 Dec; 7(12):643. PubMed ID: 29233975
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of white blood cell counts at diagnosis and during follow-up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosis.
    Buxhofer-Ausch V; Gisslinger B; Schalling M; Gleiss A; Schiefer AI; Müllauer L; Thiele J; Kralovics R; Gisslinger H
    Br J Haematol; 2017 Oct; 179(1):166-169. PubMed ID: 27432009
    [No Abstract]   [Full Text] [Related]  

  • 3. Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis.
    Gowin K; Coakley M; Kosiorek H; Mesa R
    Haematologica; 2016 Oct; 101(10):e405-e406. PubMed ID: 27354022
    [No Abstract]   [Full Text] [Related]  

  • 4. [Classification and diagnosis of essential thrombocythemia].
    Kirito K
    Rinsho Byori; 2012 Jun; 60(6):553-9. PubMed ID: 22880233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
    Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO classification of myeloproliferative neoplasms (MPN): A critical update.
    Kvasnicka HM
    Curr Hematol Malig Rep; 2013 Dec; 8(4):333-41. PubMed ID: 24146204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow fibrosis and diagnosis of essential thrombocythemia.
    Thiele J; Kvasnicka HM; Vardiman JW; Orazi A; Franco V; Gisslinger H; Birgegard G; Griesshammer M; Tefferi A
    J Clin Oncol; 2009 Dec; 27(34):e220-1; author reply e222-3. PubMed ID: 19858378
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis.
    Passamonti F; Mora B; Barraco D; Maffioli M
    Curr Hematol Malig Rep; 2018 Jun; 13(3):173-182. PubMed ID: 29713873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis.
    Rupoli S; Goteri G; Picardi P; Micucci G; Canafoglia L; Scortechini AR; Federici I; Giantomassi F; Da Lio L; Zizzi A; Honorati E; Leoni P
    Diagn Pathol; 2015 Apr; 10():29. PubMed ID: 25885405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute megakaryoblastic leukaemia or acute myelofibrosis?
    Manoharan A; Islam A
    Br J Haematol; 1979 Sep; 43(1):157-8. PubMed ID: 574391
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic myelofibrosis in children: primary myelofibrosis, essential thrombocythemia, or transient process?
    Slone JS; Smith MC; Seegmiller AC; Sidonio RF; Yang E
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):559-65. PubMed ID: 23799525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy.
    Tefferi A
    Am J Hematol; 2008 Jun; 83(6):491-7. PubMed ID: 18429051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bone marrow biopsy essential for the diagnosis of essential thrombocythemia?
    Tefferi A
    Leuk Lymphoma; 2006 Sep; 47(9):1724-5. PubMed ID: 17064976
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ
    Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPL immunohistochemical expression as a novel marker for essential thrombocythemia and primary myelofibrosis differential diagnosis.
    Ponce CC; Chauffaille Mde L; Ihara SS; Silva MR
    Leuk Res; 2012 Jan; 36(1):93-7. PubMed ID: 21752469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Leukemia; 2008 Jan; 22(1):194-5. PubMed ID: 17625603
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of megakaryoblastic leukemia showing features like primary myelofibrosis].
    Takizawa S; Sanada M; Tsukada T; Koike T; Shibata A
    Rinsho Ketsueki; 1984 Dec; 25(12):1967-72. PubMed ID: 6543457
    [No Abstract]   [Full Text] [Related]  

  • 20. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.